CO8.3 - Shared frailty excess hazard modelling in presence of between clusters heterogeneity and inappropriate life tables: an example from chronic kidney disease epidemiology
S. Lavaud(Centre National de la Recherche Scientifique), Juste Goungounga(Centre National de la Recherche Scientifique), Roch Giorgi(Inserm), Sahar Bayat-Makoei(Centre National de la Recherche Scientifique), Hadrien Charvat(Juntendo University), Cécile Couchoud(Agence de la Biomédecine), Valérie Jooste(Inserm)
Cited by 0
Related Papers
Global burden of cancer in 2020 attributable to alcohol consumption: a population-based study
|The Lancet Oncology|2021|684
Results from the ERA-EDTA Registry indicate a high mortality due to COVID-19 in dialysis patients and kidney transplant recipients across Europe
|Kidney International|2020|502
Association of Animal and Plant Protein Intake With All-Cause and Cause-Specific Mortality in a Japanese Cohort
|JAMA Internal Medicine|2019|204
Long-term survival and cure fraction estimates for childhood cancer in Europe (EUROCARE-6): results from a population-based study
|The Lancet Oncology|2022|184
Socioeconomic inequalities in cancer mortality between and within countries in Europe: a population-based study
|The Lancet Regional Health - Europe|2022|155